The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease

Clalit Health Services

Status: Unknown

Conditions: Connective Tissue Disease; Idiopathic Pulmonary Fibrosis; Interstitial Lung Disease

Study type: Observational

Funder types: Other

Identifiers

NCT01809574

225-12-MMC

Details and patient eligibility

About

We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to improved outcomes.

Enrollment: 60 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age above 18 years old
• ILD according to ATS/ERS guidelines
• Signed inform consent

Exclusion criteria

• Previous lung surgery
• Other significant systemic disease